Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | CYP1A1 |
| Upstream (Parents) |
|---|
| (<<) ADRBK2 → CYP1A1 |
| (<<) CDH24 → CYP1A1 |
| (<<) CEBPA → CYP1A1 |
| (<<) DMPK → CYP1A1 |
| (<<) GPR150 → CYP1A1 |
| (<<) HDAC8 → CYP1A1 |
| (<<) KLF2 → CYP1A1 |
| (<<) MYL6B → CYP1A1 |
| (<<) NAV2 → CYP1A1 |
| (<<) RPL26L1 → CYP1A1 |
| (<<) RRP1 → CYP1A1 |
| (<<) RXRA → CYP1A1 |
| (<<) TAF9 → CYP1A1 |
| Downstream (Children) |
|---|
| CYP1A1 → CDC42 (>>) |
| CYP1A1 → FZD5 (>>) |
| CYP1A1 → RPL22L1 (>>) |
